Expanded Access Program of Ponatinib

Name: Expanded Access Program of Ponatinib
License: Public Domain

Ariad Pharmaceuticals

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

chronic myeloid leukemia (cml), philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all), ponatinib, tyrosine kinase inhibitor, expanded access

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 875908
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.